Structure

Physi-Chem Properties

Molecular Weight:  298.08
Volume:  299.778
LogP:  3.24
LogD:  2.59
LogS:  -3.346
# Rotatable Bonds:  2
TPSA:  79.9
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.759
Synthetic Accessibility Score:  2.381
Fsp3:  0.118
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.836
MDCK Permeability:  1.680144305282738e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.919
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.027
Plasma Protein Binding (PPB):  98.48841094970703%
Volume Distribution (VD):  0.385
Pgp-substrate:  2.3418474197387695%

ADMET: Metabolism

CYP1A2-inhibitor:  0.933
CYP1A2-substrate:  0.896
CYP2C19-inhibitor:  0.808
CYP2C19-substrate:  0.066
CYP2C9-inhibitor:  0.821
CYP2C9-substrate:  0.872
CYP2D6-inhibitor:  0.755
CYP2D6-substrate:  0.762
CYP3A4-inhibitor:  0.476
CYP3A4-substrate:  0.173

ADMET: Excretion

Clearance (CL):  5.433
Half-life (T1/2):  0.675

ADMET: Toxicity

hERG Blockers:  0.022
Human Hepatotoxicity (H-HT):  0.074
Drug-inuced Liver Injury (DILI):  0.663
AMES Toxicity:  0.174
Rat Oral Acute Toxicity:  0.464
Maximum Recommended Daily Dose:  0.198
Skin Sensitization:  0.846
Carcinogencity:  0.24
Eye Corrosion:  0.018
Eye Irritation:  0.94
Respiratory Toxicity:  0.163

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC101366

Natural Product ID:  NPC101366
Common Name*:   2'-O-Methylabronisoflavone
IUPAC Name:   5,7-dihydroxy-3-(2-methoxyphenyl)-6-methylchromen-4-one
Synonyms:   2'-O-Methylabronisoflavone
Standard InCHIKey:  MNTFQBBYPKFUJE-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C17H14O5/c1-9-12(18)7-14-15(16(9)19)17(20)11(8-22-14)10-5-3-4-6-13(10)21-2/h3-8,18-19H,1-2H3
SMILES:  Cc1c(cc2c(c1O)c(=O)c(co2)c1ccccc1OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL496643
PubChem CID:   5482494
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002901] Isoflav-2-enes
          • [CHEMONTID:0000494] Isoflavones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16456 Mirabilis jalapa Species Nyctaginaceae Eukaryota n.a. n.a. n.a. PMID[11277746]
NPO33416 boerhaavia diffusa Species n.a. n.a. roots n.a. n.a. PMID[16792408]
NPO33416 boerhaavia diffusa Species n.a. n.a. n.a. n.a. n.a. PMID[23914900]
NPO16456 Mirabilis jalapa Species Nyctaginaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16456 Mirabilis jalapa Species Nyctaginaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16456 Mirabilis jalapa Species Nyctaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20 Organism Candida albicans Candida albicans IC50 = 25.0 ug.mL-1 PMID[448930]
NPT20 Organism Candida albicans Candida albicans IC50 = 16.0 ug.mL-1 PMID[448930]
NPT548 Tissue Ileum Cavia porcellus Emax = 36.8 % PMID[448931]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC101366 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9926 High Similarity NPC52789
0.9926 High Similarity NPC26051
0.9926 High Similarity NPC55832
0.9926 High Similarity NPC268204
0.9925 High Similarity NPC295384
0.9852 High Similarity NPC219917
0.9852 High Similarity NPC213659
0.9852 High Similarity NPC48624
0.9852 High Similarity NPC204985
0.9852 High Similarity NPC259166
0.9852 High Similarity NPC253822
0.9852 High Similarity NPC80962
0.9852 High Similarity NPC172250
0.9852 High Similarity NPC326109
0.9852 High Similarity NPC144118
0.9852 High Similarity NPC215311
0.9851 High Similarity NPC12175
0.9851 High Similarity NPC90665
0.9851 High Similarity NPC309154
0.9851 High Similarity NPC55162
0.9851 High Similarity NPC279668
0.9851 High Similarity NPC278323
0.9779 High Similarity NPC469404
0.9778 High Similarity NPC283429
0.9776 High Similarity NPC181124
0.9776 High Similarity NPC209560
0.9776 High Similarity NPC162680
0.9776 High Similarity NPC7013
0.9776 High Similarity NPC294409
0.9776 High Similarity NPC303644
0.9776 High Similarity NPC116632
0.971 High Similarity NPC476055
0.9701 High Similarity NPC235428
0.9701 High Similarity NPC87545
0.9638 High Similarity NPC476178
0.9638 High Similarity NPC51887
0.9638 High Similarity NPC117836
0.9638 High Similarity NPC475705
0.9632 High Similarity NPC477956
0.963 High Similarity NPC472419
0.9627 High Similarity NPC39426
0.9627 High Similarity NPC234560
0.9568 High Similarity NPC234629
0.9568 High Similarity NPC311741
0.9559 High Similarity NPC21350
0.9556 High Similarity NPC98115
0.9556 High Similarity NPC1486
0.9556 High Similarity NPC186838
0.9556 High Similarity NPC477242
0.9556 High Similarity NPC168105
0.9556 High Similarity NPC66349
0.9556 High Similarity NPC274109
0.9556 High Similarity NPC477244
0.9556 High Similarity NPC477243
0.9556 High Similarity NPC12165
0.9556 High Similarity NPC150399
0.9556 High Similarity NPC41461
0.9556 High Similarity NPC25287
0.9556 High Similarity NPC249606
0.9504 High Similarity NPC266572
0.9493 High Similarity NPC470087
0.9493 High Similarity NPC321980
0.9493 High Similarity NPC110969
0.9493 High Similarity NPC470089
0.9493 High Similarity NPC3188
0.9489 High Similarity NPC470211
0.9489 High Similarity NPC18260
0.9489 High Similarity NPC78913
0.9485 High Similarity NPC317119
0.9485 High Similarity NPC153979
0.9485 High Similarity NPC212767
0.9481 High Similarity NPC131039
0.9481 High Similarity NPC156092
0.9481 High Similarity NPC13575
0.9437 High Similarity NPC317492
0.9433 High Similarity NPC237635
0.9433 High Similarity NPC104406
0.9433 High Similarity NPC97716
0.9433 High Similarity NPC222298
0.9433 High Similarity NPC201731
0.9433 High Similarity NPC79469
0.9433 High Similarity NPC24673
0.9433 High Similarity NPC51070
0.9424 High Similarity NPC226636
0.9424 High Similarity NPC11561
0.942 High Similarity NPC159275
0.942 High Similarity NPC172986
0.942 High Similarity NPC270883
0.942 High Similarity NPC261227
0.942 High Similarity NPC241100
0.942 High Similarity NPC11056
0.9416 High Similarity NPC471620
0.9416 High Similarity NPC251681
0.9416 High Similarity NPC243528
0.9416 High Similarity NPC201395
0.9412 High Similarity NPC193792
0.9407 High Similarity NPC103842
0.9407 High Similarity NPC286336
0.9403 High Similarity NPC212631
0.9403 High Similarity NPC205468
0.9403 High Similarity NPC129132
0.9403 High Similarity NPC257756
0.9403 High Similarity NPC87231
0.9403 High Similarity NPC182428
0.9366 High Similarity NPC168085
0.9366 High Similarity NPC6511
0.9366 High Similarity NPC39195
0.9357 High Similarity NPC169591
0.9357 High Similarity NPC39329
0.9357 High Similarity NPC149026
0.9357 High Similarity NPC257097
0.9357 High Similarity NPC310130
0.9357 High Similarity NPC150408
0.9357 High Similarity NPC106985
0.9357 High Similarity NPC68104
0.9357 High Similarity NPC166138
0.9357 High Similarity NPC301751
0.9357 High Similarity NPC18585
0.9357 High Similarity NPC91560
0.9357 High Similarity NPC143896
0.9357 High Similarity NPC75049
0.9357 High Similarity NPC221432
0.9357 High Similarity NPC164980
0.9357 High Similarity NPC175504
0.9357 High Similarity NPC245482
0.9353 High Similarity NPC4743
0.9353 High Similarity NPC213322
0.9353 High Similarity NPC147688
0.9353 High Similarity NPC103362
0.9353 High Similarity NPC205006
0.9353 High Similarity NPC118840
0.9353 High Similarity NPC312391
0.9353 High Similarity NPC64908
0.9353 High Similarity NPC282300
0.9353 High Similarity NPC156590
0.9353 High Similarity NPC324386
0.9348 High Similarity NPC472366
0.9348 High Similarity NPC96565
0.9348 High Similarity NPC301217
0.9348 High Similarity NPC220062
0.9348 High Similarity NPC216978
0.9348 High Similarity NPC303633
0.9348 High Similarity NPC217186
0.9348 High Similarity NPC53181
0.9348 High Similarity NPC55018
0.9343 High Similarity NPC266597
0.9343 High Similarity NPC228661
0.9343 High Similarity NPC250266
0.9333 High Similarity NPC56031
0.9333 High Similarity NPC192304
0.9333 High Similarity NPC139813
0.9333 High Similarity NPC159623
0.9333 High Similarity NPC337373
0.9333 High Similarity NPC188646
0.9333 High Similarity NPC175098
0.9333 High Similarity NPC82225
0.9333 High Similarity NPC472365
0.9333 High Similarity NPC27643
0.9333 High Similarity NPC28753
0.9333 High Similarity NPC20560
0.9333 High Similarity NPC144051
0.9333 High Similarity NPC263670
0.9333 High Similarity NPC294593
0.9333 High Similarity NPC242294
0.9333 High Similarity NPC18877
0.9333 High Similarity NPC223354
0.9333 High Similarity NPC312318
0.9333 High Similarity NPC204960
0.9328 High Similarity NPC313618
0.9328 High Similarity NPC64359
0.9328 High Similarity NPC308037
0.9328 High Similarity NPC262359
0.9301 High Similarity NPC38545
0.9301 High Similarity NPC171916
0.9296 High Similarity NPC473077
0.9296 High Similarity NPC23728
0.9296 High Similarity NPC308200
0.9296 High Similarity NPC296998
0.9296 High Similarity NPC110303
0.9291 High Similarity NPC319752
0.9291 High Similarity NPC236766
0.9291 High Similarity NPC473013
0.9291 High Similarity NPC197252
0.9291 High Similarity NPC473015
0.9291 High Similarity NPC209040
0.9291 High Similarity NPC273538
0.9291 High Similarity NPC224714
0.9291 High Similarity NPC184649
0.9291 High Similarity NPC271288
0.9291 High Similarity NPC216538
0.9291 High Similarity NPC303185
0.9286 High Similarity NPC32739
0.9286 High Similarity NPC473042
0.9286 High Similarity NPC306829
0.9286 High Similarity NPC78
0.9286 High Similarity NPC66515
0.9286 High Similarity NPC166482
0.9286 High Similarity NPC194432
0.9286 High Similarity NPC265040
0.9286 High Similarity NPC202981

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC101366 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9627 High Similarity NPD1510 Phase 2
0.9328 High Similarity NPD1240 Approved
0.9291 High Similarity NPD4378 Clinical (unspecified phase)
0.9191 High Similarity NPD1607 Approved
0.9137 High Similarity NPD1549 Phase 2
0.9103 High Similarity NPD4380 Phase 2
0.9065 High Similarity NPD1550 Clinical (unspecified phase)
0.9065 High Similarity NPD1552 Clinical (unspecified phase)
0.9021 High Similarity NPD7410 Clinical (unspecified phase)
0.8993 High Similarity NPD2796 Approved
0.8792 High Similarity NPD2393 Clinical (unspecified phase)
0.8784 High Similarity NPD7411 Suspended
0.8742 High Similarity NPD7075 Discontinued
0.8733 High Similarity NPD8443 Clinical (unspecified phase)
0.8667 High Similarity NPD7819 Suspended
0.8667 High Similarity NPD7096 Clinical (unspecified phase)
0.8611 High Similarity NPD1878 Clinical (unspecified phase)
0.86 High Similarity NPD6801 Discontinued
0.86 High Similarity NPD1934 Approved
0.8562 High Similarity NPD1511 Approved
0.8543 High Similarity NPD2801 Approved
0.8497 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8483 Intermediate Similarity NPD3750 Approved
0.8472 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD2935 Discontinued
0.8446 Intermediate Similarity NPD1512 Approved
0.8435 Intermediate Similarity NPD6799 Approved
0.8431 Intermediate Similarity NPD7768 Phase 2
0.8431 Intermediate Similarity NPD3882 Suspended
0.8414 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8414 Intermediate Similarity NPD2800 Approved
0.8408 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8392 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8389 Intermediate Similarity NPD920 Approved
0.838 Intermediate Similarity NPD6651 Approved
0.8333 Intermediate Similarity NPD1551 Phase 2
0.8288 Intermediate Similarity NPD1243 Approved
0.828 Intermediate Similarity NPD6232 Discontinued
0.8258 Intermediate Similarity NPD3749 Approved
0.8255 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8255 Intermediate Similarity NPD2533 Approved
0.8255 Intermediate Similarity NPD2534 Approved
0.8255 Intermediate Similarity NPD2532 Approved
0.825 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8243 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD943 Approved
0.8239 Intermediate Similarity NPD7473 Discontinued
0.8227 Intermediate Similarity NPD2313 Discontinued
0.8224 Intermediate Similarity NPD6599 Discontinued
0.8217 Intermediate Similarity NPD6959 Discontinued
0.8187 Intermediate Similarity NPD3818 Discontinued
0.8153 Intermediate Similarity NPD5494 Approved
0.8151 Intermediate Similarity NPD2344 Approved
0.8148 Intermediate Similarity NPD5953 Discontinued
0.8138 Intermediate Similarity NPD2799 Discontinued
0.8138 Intermediate Similarity NPD3748 Approved
0.8129 Intermediate Similarity NPD3817 Phase 2
0.8099 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8071 Intermediate Similarity NPD2798 Approved
0.8063 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD6166 Phase 2
0.8063 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD5403 Approved
0.8025 Intermediate Similarity NPD7286 Phase 2
0.8013 Intermediate Similarity NPD5401 Approved
0.7962 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD2309 Approved
0.7922 Intermediate Similarity NPD3226 Approved
0.7914 Intermediate Similarity NPD7054 Approved
0.7898 Intermediate Similarity NPD5402 Approved
0.7879 Intermediate Similarity NPD6559 Discontinued
0.7875 Intermediate Similarity NPD1247 Approved
0.7872 Intermediate Similarity NPD1203 Approved
0.7866 Intermediate Similarity NPD7472 Approved
0.7866 Intermediate Similarity NPD7074 Phase 3
0.7862 Intermediate Similarity NPD919 Approved
0.7847 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7842 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD7390 Discontinued
0.7818 Intermediate Similarity NPD6797 Phase 2
0.781 Intermediate Similarity NPD1548 Phase 1
0.7785 Intermediate Similarity NPD2346 Discontinued
0.7771 Intermediate Similarity NPD7251 Discontinued
0.7748 Intermediate Similarity NPD4628 Phase 3
0.7746 Intermediate Similarity NPD1470 Approved
0.7725 Intermediate Similarity NPD7808 Phase 3
0.7725 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD1610 Phase 2
0.7708 Intermediate Similarity NPD4908 Phase 1
0.7708 Intermediate Similarity NPD6832 Phase 2
0.7697 Intermediate Similarity NPD5844 Phase 1
0.7692 Intermediate Similarity NPD7458 Discontinued
0.7687 Intermediate Similarity NPD230 Phase 1
0.7682 Intermediate Similarity NPD2654 Approved
0.7681 Intermediate Similarity NPD9545 Approved
0.7677 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7664 Intermediate Similarity NPD9493 Approved
0.766 Intermediate Similarity NPD9717 Approved
0.766 Intermediate Similarity NPD3972 Approved
0.7651 Intermediate Similarity NPD7033 Discontinued
0.7651 Intermediate Similarity NPD4308 Phase 3
0.7622 Intermediate Similarity NPD1164 Approved
0.7607 Intermediate Similarity NPD5710 Approved
0.7607 Intermediate Similarity NPD5711 Approved
0.7603 Intermediate Similarity NPD3764 Approved
0.7603 Intermediate Similarity NPD3268 Approved
0.76 Intermediate Similarity NPD6100 Approved
0.76 Intermediate Similarity NPD6099 Approved
0.7589 Intermediate Similarity NPD1201 Approved
0.7589 Intermediate Similarity NPD422 Phase 1
0.7586 Intermediate Similarity NPD4360 Phase 2
0.7586 Intermediate Similarity NPD4363 Phase 3
0.7561 Intermediate Similarity NPD3926 Phase 2
0.7543 Intermediate Similarity NPD4361 Phase 2
0.7543 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD7003 Approved
0.7516 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1465 Phase 2
0.75 Intermediate Similarity NPD2797 Approved
0.75 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD5404 Approved
0.7483 Intermediate Similarity NPD5408 Approved
0.7483 Intermediate Similarity NPD5406 Approved
0.7483 Intermediate Similarity NPD5405 Approved
0.7471 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD4288 Approved
0.745 Intermediate Similarity NPD5124 Phase 1
0.745 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD1729 Discontinued
0.7434 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD3225 Approved
0.7431 Intermediate Similarity NPD1876 Approved
0.7397 Intermediate Similarity NPD9494 Approved
0.7383 Intermediate Similarity NPD4307 Phase 2
0.7379 Intermediate Similarity NPD3267 Approved
0.7379 Intermediate Similarity NPD3266 Approved
0.7374 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD2296 Approved
0.7333 Intermediate Similarity NPD1933 Approved
0.7333 Intermediate Similarity NPD447 Suspended
0.732 Intermediate Similarity NPD1471 Phase 3
0.7319 Intermediate Similarity NPD1241 Discontinued
0.7297 Intermediate Similarity NPD4625 Phase 3
0.7297 Intermediate Similarity NPD3027 Phase 3
0.7292 Intermediate Similarity NPD1608 Approved
0.7289 Intermediate Similarity NPD7229 Phase 3
0.7267 Intermediate Similarity NPD5889 Approved
0.7267 Intermediate Similarity NPD1613 Approved
0.7267 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5890 Approved
0.7261 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD4287 Approved
0.7254 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD411 Approved
0.7248 Intermediate Similarity NPD1296 Phase 2
0.723 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD7584 Approved
0.7222 Intermediate Similarity NPD37 Approved
0.7222 Intermediate Similarity NPD6844 Discontinued
0.7219 Intermediate Similarity NPD3751 Discontinued
0.7219 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD1019 Discontinued
0.7192 Intermediate Similarity NPD1283 Approved
0.7182 Intermediate Similarity NPD6777 Approved
0.7182 Intermediate Similarity NPD6781 Approved
0.7182 Intermediate Similarity NPD6778 Approved
0.7182 Intermediate Similarity NPD6776 Approved
0.7182 Intermediate Similarity NPD6780 Approved
0.7182 Intermediate Similarity NPD6782 Approved
0.7182 Intermediate Similarity NPD6779 Approved
0.7168 Intermediate Similarity NPD8313 Approved
0.7168 Intermediate Similarity NPD8312 Approved
0.7163 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD6104 Discontinued
0.7134 Intermediate Similarity NPD3295 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD6798 Discontinued
0.7133 Intermediate Similarity NPD1651 Approved
0.7123 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6280 Approved
0.7117 Intermediate Similarity NPD6279 Approved
0.7108 Intermediate Similarity NPD6234 Discontinued
0.7107 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD6585 Discontinued
0.7091 Intermediate Similarity NPD4966 Approved
0.7091 Intermediate Similarity NPD4967 Phase 2
0.7091 Intermediate Similarity NPD4965 Approved
0.7083 Intermediate Similarity NPD17 Approved
0.708 Intermediate Similarity NPD74 Approved
0.708 Intermediate Similarity NPD9266 Approved
0.7073 Intermediate Similarity NPD5761 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data